A detailed history of Manufacturers Life Insurance Company, The transactions in Novo Cure LTD stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 202,027 shares of NVCR stock, worth $6.26 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
202,027
Previous 187,772 7.59%
Holding current value
$6.26 Million
Previous $3.22 Million 1.83%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$15.61 - $23.34 $222,520 - $332,711
14,255 Added 7.59%
202,027 $3.16 Million
Q2 2024

Aug 14, 2024

BUY
$11.83 - $24.05 $448,960 - $912,721
37,951 Added 25.33%
187,772 $3.22 Million
Q1 2024

May 14, 2024

BUY
$12.42 - $17.29 $360,602 - $501,997
29,034 Added 24.04%
149,821 $2.34 Million
Q4 2023

Feb 13, 2024

BUY
$11.13 - $15.78 $262,768 - $372,550
23,609 Added 24.29%
120,787 $1.8 Million
Q3 2023

Nov 15, 2023

BUY
$16.15 - $42.35 $109,432 - $286,963
6,776 Added 7.5%
97,178 $1.57 Million
Q2 2023

Aug 11, 2023

BUY
$40.29 - $82.51 $669,337 - $1.37 Million
16,613 Added 22.51%
90,402 $3.75 Million
Q1 2023

May 15, 2023

BUY
$56.44 - $118.81 $779,210 - $1.64 Million
13,806 Added 18.71%
87,595 $5.27 Million
Q4 2022

Aug 11, 2023

SELL
$63.98 - $85.37 $190,276 - $253,890
-2,974 Reduced 3.87%
73,789 $5.41 Million
Q4 2022

Feb 13, 2023

SELL
$63.98 - $85.37 $190,276 - $253,890
-2,974 Reduced 3.87%
73,789 $5.41 Million
Q3 2022

Aug 11, 2023

BUY
$67.99 - $89.57 $364,494 - $480,184
5,361 Added 7.51%
76,763 $5.83 Million
Q3 2022

Nov 03, 2022

BUY
$67.99 - $89.57 $364,494 - $480,184
5,361 Added 7.51%
76,763 $5.91 Million
Q2 2022

Aug 11, 2023

BUY
$56.6 - $89.9 $891,619 - $1.42 Million
15,753 Added 28.31%
71,402 $4.96 Million
Q2 2022

Aug 15, 2022

BUY
$56.6 - $89.9 $935,428 - $1.49 Million
16,527 Added 30.12%
71,402 $5.17 Million
Q1 2022

Aug 11, 2023

SELL
$60.15 - $84.52 $1.92 Million - $2.7 Million
-31,946 Reduced 36.47%
55,649 $4.61 Million
Q1 2022

Aug 15, 2022

BUY
$60.15 - $84.52 $3.3 Million - $4.64 Million
54,875 New
54,875 $4.61 Million
Q3 2021

Nov 12, 2021

SELL
$116.17 - $194.55 $1.74 Million - $2.92 Million
-15,014 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$130.4 - $225.58 $5,737 - $9,925
44 Added 0.29%
15,014 $3.33 Million
Q1 2021

May 03, 2021

SELL
$124.11 - $190.17 $16,010 - $24,531
-129 Reduced 0.85%
14,970 $1.98 Million
Q4 2020

Feb 12, 2021

BUY
$112.16 - $174.14 $54,397 - $84,457
485 Added 3.32%
15,099 $2.61 Million
Q2 2020

Aug 10, 2020

SELL
$57.2 - $74.41 $3.01 Million - $3.92 Million
-52,631 Reduced 78.27%
14,614 $1.15 Million
Q1 2020

May 15, 2020

BUY
$57.05 - $95.75 $171,834 - $288,399
3,012 Added 4.69%
67,245 $4.53 Million
Q4 2019

Feb 14, 2020

SELL
$68.3 - $93.8 $67,685 - $92,955
-991 Reduced 1.52%
64,233 $5.8 Million
Q3 2019

Nov 12, 2019

BUY
$61.86 - $97.8 $692,893 - $1.1 Million
11,201 Added 20.73%
65,224 $4.79 Million
Q2 2019

Aug 14, 2019

BUY
$42.22 - $63.23 $338,519 - $506,978
8,018 Added 17.43%
54,023 $3.42 Million
Q1 2019

May 13, 2019

SELL
$31.96 - $56.12 $576,782 - $1.01 Million
-18,047 Reduced 28.18%
46,005 $2.22 Million
Q4 2018

Feb 14, 2019

SELL
$28.72 - $52.63 $1.33 Million - $2.43 Million
-46,234 Reduced 41.92%
64,052 $2.15 Million
Q3 2018

Nov 14, 2018

BUY
$32.0 - $52.4 $1.82 Million - $2.99 Million
56,995 Added 106.95%
110,286 $5.78 Million
Q2 2018

Aug 14, 2018

BUY
$19.85 - $32.0 $176,268 - $284,160
8,880 Added 20.0%
53,291 $1.67 Million
Q1 2018

May 15, 2018

SELL
$19.3 - $23.65 $13,683 - $16,767
-709 Reduced 1.57%
44,411 $968,000
Q4 2017

Feb 08, 2018

BUY
$16.3 - $21.9 $2,282 - $3,066
140 Added 0.31%
45,120 $911,000
Q3 2017

Nov 14, 2017

BUY
$18.05 - $21.75 $811,889 - $978,315
44,980
44,980 $892,000

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $3.25B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.